A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Oronsky B, Goyal S, Kim MM, Cabrales P, Lybeck M, Caroen S, Oronsky N, Burbano E, Carter C, Oronsky A.Transl Oncol. 2018 Jun;11(3):771-778. doi: 10.1016/j.tranon.2018.03.014. Epub 2018 Apr 23.PMID: 29698934 Free PMC article. Review.

Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Oronsky B, Reid TR, Oronsky A, Caroen S, Carter CA, Cabrales P.Oncotarget. 2018 May 4;9(34):23439-23442. doi: 10.18632/oncotarget.25211. eCollection 2018 May 4.PMID: 29805745 Free PMC article.

Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Oronsky B, Oronsky N, Cabrales P.J Cell Mol Med. 2018 Oct;22(10):5076-5082. doi: 10.1111/jcmm.13791. Epub 2018 Jul 16.PMID: 30010241 Free PMC article.

Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Ojemuyiwa M, Zeman K, Spira A, Oronsky B, Ray C, Trepel JB, Lee MJ, Onyiuke I, Brzezniak C.Clin Case Rep. 2018 Nov 5;6(12):2478-2481. doi: 10.1002/ccr3.1880. eCollection 2018 Dec.PMID: 30564353 Free PMC article.

RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-alpha on Monocytes/Macrophages.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Cabrales P.Transl Oncol. 2019 Apr;12(4):626-632. doi: 10.1016/j.tranon.2018.12.001. Epub 2019 Feb 6.PMID: 30738349 Free PMC article.